Your Alignment Has a Half-Life
By Matt Wilkinson
How Synthetic Customer Simulation De-Risks Launches
By Matt Wilkinson
Your Roadmap Isn't the Whole Story
By Jasmine Gruia-Gray
The Idea I Kept Writing About Became a Book You Can Buy
By Matt Wilkinson
Post-Launch Signals: Knowing When to Act Fast vs. When to Wait
By Jasmine Gruia-Gray
How to Fix Life Science Go-to-Market Gaps in 2026
By Matt Wilkinson
Nobody Has a Formula for Your Portfolio Split
By Jasmine Gruia-Gray
Your strategy was right but organisational gravity still struck
By Matt Wilkinson
When Agile Beats Stage-Gate: The Line Extension Case
By Jasmine Gruia-Gray
AI persona tools for life sciences, compared
By Matt Wilkinson
Marketing's seventh wave has a buyer problem
By Matt Wilkinson
Stage-Gate's Eight Advances, and the Two Most Teams Use
By Jasmine Gruia-Gray
Your team is botsitting, here is the bill
By Matt Wilkinson
Your portfolio revenue stopped telling you the truth
By Jasmine Gruia-Gray
A Brand is trust and AI slop can break it fast
By Matt Wilkinson